All News

Found 2,410 articles

• Why This Massachusetts Biotech Could be the Tesla of Healthcare

  8/22/2017

• CRISPR Announces Collaboration With Massachusetts General Hospital To Research Use Of CRISPR/Cas9 In T Cell Cancer Therapies

  8/22/2017

• Abeona Therapeutics To Host Gene Therapy R&D Day On October 11, 2017

  8/17/2017

• Abeona Therapeutics Announces Pivotal Expansion Of ABO-102 Gene Therapy Clinical Trials In Sanfilippo Syndrome Type A

  8/16/2017

• Applied StemCell, Inc. Awarded $1.3 Mil USD From NIH For TARGAT Gene Editing

  8/16/2017

• CRISPR’s Bright Future, Real Science and the Science Fiction of Designer Babies

  8/15/2017

• Abeona Therapeutics Reports Second Quarter 2017 Financial Results And Recent Business Highlights

  8/15/2017

• CRISPR Announces Second Quarter 2017 Financial Results And Provides Business Update

  8/11/2017

• Integrated DNA Technologies Stay On-Target With Novel, High-Fidelity Cas9

  8/9/2017

• European Patent Office To Grant MilliporeSigma's Patent Application For CRISPR Technology

  8/3/2017

• Massachusetts’ Homology Medicines Snags $83.5M to Advance AMEnDR into Human Trials

  8/1/2017

• Integrated DNA Technologies Launches First Cas9 Enzyme That Drastically Reduces CRISPR Off-Target Effects Without Significant Loss Of On-Target Activity

  8/1/2017

• Horizon Discovery Announces Release Of High Quality, Well Annotated CHO Genome Sequence To Drive Innovation In Bioproduction

  8/1/2017

• Intellia Announces Second Quarter 2017 Financial Results

  8/1/2017

• CRISPR Appoints Dr. Tony W. Ho To Head Research & Development

  8/1/2017

• CRISPR To Lose Its CFO In September, Hunt For Successor Begins

  7/27/2017

• CRISPR, Intellia, Caribou Biosciences And ERS Genomics Announce Appellate Brief Seeking Reversal Of U.S. Patent Board Decision On CRISPR/Cas9 Gene Editing

  7/26/2017

• Cellectis Granted Patent For CRISPR Use In T-Cells

  7/25/2017

• Abeona Therapeutics Announces Appointment Of Juan Ruiz As Chief Medical Officer

  7/25/2017

• Intellia Names Moncef Slaoui, Ph.D. And Frank Verwiel, M.D. To Its Board Of Directors And Establishes A Science And Technology Committee

  7/24/2017